Susana Machado is an EMBO Postdoctoral Fellow Researcher at IOCB Prague, with a strong background in biophotonics, systems biology, and gene therapy. Prior experience includes a Trainee position at the European Commission, where analysis of financial and technological returns from EU funding was conducted. As a Research Assistant at Universidade do Algarve, Susana contributed to bioinformatic tool development for stem cell research and established an in vivo delivery system for gene therapy in the mouse retina. Earlier experience includes a Research Consultant role at Weill Cornell Medical College in Qatar, focusing on cationic lipids for gene/siRNA delivery. Susana holds a PhD in Disease Mechanisms and Regenerative Medicine, an MSc in Biomedical Sciences, and a BSc in Biochemistry from the University of Algarve.
This person is not in any teams
IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
1 followers
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is a leading scientific institution in the Czech Republic, recognized internationally. Its primary mission is basic research in the fields of chemical biology and medicinal chemistry, organic and material oriented chemistry, chemistry of natural compounds, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. Today, over 600 employees including 180 students in 45 research and service groups are involved in a broad spectra of disciplines, which results in more than 250 publications per year, including papers in the most cited prestigious journals such as Nature or Science. The Institute’s emphasis on interaction between chemistry and other sciences leads frequently to medicinal applications. An integral part of the mission of the Institute is, therefore, to transfer the scientific results into assets which help people to live better lives. Together with the research expertise, a system of technology transfer, IP management and commercialization have intensively been built-up. Through its subsidiary company IOCB TTO, the Institute helps scientists to transform ideas into patents and matches their research results with interests of commercial partners to bring novel ideas to human use or technology market.